当前位置:首页 - 行情中心 - 皓宸医疗(002622) - 财务分析 - 现金流量表

皓宸医疗

(002622)

  

流通市值:26.21亿  总市值:26.21亿
流通股本:8.40亿   总股本:8.40亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金314,418,542.07142,342,626.53810,861,968.35607,795,323.05
  收到的税费返还2,376,818.041,243,660.24,447,160.53,808,545.49
  收到其他与经营活动有关的现金2,487,426.251,307,099.5310,858,246.646,767,998.74
  经营活动现金流入小计319,282,786.36144,893,386.26826,167,375.49618,371,867.28
  购买商品、接受劳务支付的现金138,603,596.4162,459,174.27205,180,693.77234,729,323.13
  支付给职工以及为职工支付的现金150,399,324.2474,373,569.07341,500,568.63240,402,552.57
  支付的各项税费7,938,136.463,366,360.0813,307,358.512,929,204.4
  支付其他与经营活动有关的现金49,931,518.2621,878,983.19173,815,724.3187,244,495.31
  经营活动现金流出小计346,872,575.37162,078,086.61733,804,345.21575,305,575.41
  经营活动产生的现金流量净额-27,589,789.01-17,184,700.3592,363,030.2843,066,291.87
二、投资活动产生的现金流量:
  处置固定资产、无形资产和其他长期资产收回的现金净额--12,05219,417.48
  收到的其他与投资活动有关的现金--714,184.71-
  投资活动现金流入的平衡项目--00
  投资活动现金流入小计--726,236.7119,417.48
  购建固定资产、无形资产和其他长期资产支付的现金2,551,228.72278,026.7513,790,314.627,266,073.11
  投资活动现金流出小计2,551,228.72278,026.7513,790,314.627,266,073.11
  投资活动产生的现金流量净额-2,551,228.72-278,026.75-13,064,077.91-7,246,655.63
三、筹资活动产生的现金流量:
  吸收投资收到的现金3,430,000---
  其中:子公司吸收少数股东投资收到的现金3,430,000---
  取得借款收到的现金--78,400,00078,400,000
  筹资活动现金流入平衡项目0-00
  筹资活动现金流入小计3,430,000-78,400,00078,400,000
  偿还债务支付的现金--88,350,00087,700,000
  分配股利、利润或偿付利息支付的现金9,709,711.073,856,999.9825,530,252.1715,557,752.19
  其中:子公司支付给少数股东的股利、利润--9,085,815.282,940,000
  支付其他与筹资活动有关的现金286,399.61151,248.2354,164,584.54496,568.34
  筹资活动现金流出小计9,996,110.684,008,248.21168,044,836.71103,754,320.53
  筹资活动产生的现金流量净额-6,566,110.68-4,008,248.21-89,644,836.71-25,354,320.53
四、汇率变动对现金及现金等价物的影响206.67105.2634.9934.99
五、现金及现金等价物净增加额-36,706,921.74-21,470,870.05-10,345,849.3510,465,350.7
  加:期初现金及现金等价物余额131,570,807.19146,570,808.67141,916,656.54141,916,656.54
  期末现金及现金等价物余额94,863,885.45125,099,938.62131,570,807.19152,382,007.24
补充资料:
  净利润-34,614,381.26--15,237,706.67-
  资产减值准备-2,881,096.74-2,030,381.08-
  固定资产和投资性房地产折旧5,518,734.04-13,731,794.92-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧5,518,734.04-13,731,794.92-
  无形资产摊销1,897,125.54-3,892,909.85-
  长期待摊费用摊销1,517,290.25-14,045,234.2-
  处置固定资产、无形资产和其他长期资产的损失-678,017.94-576,307.24-
  固定资产报废损失0-209,844.03-
  公允价值变动损失0---
  财务费用20,256,561.25-43,375,298.82-
  投资损失-4,349,700.1-3,704,345.84-
  递延所得税51,294.7-1,835,830.34-
  其中:递延所得税资产减少430,392.77-2,771,303.06-
    递延所得税负债增加-379,098.07--935,472.72-
  存货的减少-2,523,284.59-11,389,727.26-
  经营性应收项目的减少39,871,991.74--28,090,974.09-
  经营性应付项目的增加-74,454,399.82-5,122,152.72-
  其他-2,316,154.17--10,277,147.44-
  融资租入固定资产--43,016,138.14-
  现金的期末余额94,863,885.45-131,570,807.19-
  减:现金的期初余额131,570,807.19-141,916,656.54-
  现金及现金等价物的净增加额-36,706,921.74--10,345,849.35-
公告日期2025-08-292025-04-262025-04-262024-10-31
审计意见(境内)带强调事项段的无保留意见
TOP↑